Lonza maintains 2017 target and says US plant and Capsugel integration on track
Lonza has reaffirmed its full-year sales and earnings forecast and updated about its US operations and the integration of Capsugel.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs